The inhibition of the ERK/JNK/p38 pathway by TD139 is particularly relevant in the context of GDM, where enhanced activation of these kinases can lead to increased production of inflammatory cytokines and subsequent placental dysfunction. Here, MAPK8 is linked to gestational diabetes.